Risk Factors for Differentiated Thyroid Carcinoma in Long-Standing Goiter: A Bolivian Clinical-Demographic Study
DOI:
https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v46i3.1290Keywords:
endemic goiter, thyroid cancer, risk factors, clinical diagnosisAbstract
Introduction: In endemic areas such as Bolivia, differentiated thyroid cancer (DTC) in patients with chronic goiter poses a diagnostic challenge. The objective was to describe the clinical factors associated with the presence of DTC in patients undergoing surgery for long-standing goiter at a tertiary care hospital.
Methods: This observational, descriptive, retrospective study (2014–2024) included 193 patients who underwent surgery for goiter at Hospital San Juan de Dios (Santa Cruz, Bolivia), with histopathological confirmation of DTC in 76 cases. Logistic regression was used to analyze clinical, demographic, and diagnostic variables, and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated.
Results and discussion: Five relevant clinical factors were identified (p < 0.05), with a malignancy (DTC) rate of 42% in the surgical cohort. Adherence to deep tissue planes or hard consistency was the most relevant factor (85.5% of cases; OR 6.66; 95% CI: 3.19–13.89), followed by rapid growth during the previous year (72.4%; OR 5.89; 95% CI: 3.54–12.84) and urban origin or migration more than 10 years previously (72.4%; OR 2.5; 95% CI: 1.34–4.62). Significant associations were also observed with cytological findings (Bethesda ≥ IV; OR 6.69) and imaging findings (TI-RADS ≥ IV; OR 3.5). In the multivariable regression analysis, adherence to deep tissue planes was the only independent variable (p = 0.024). The association with urban origin could be related to environmental factors or greater access to diagnostic testing.
Conclusion: In this series of patients undergoing surgery for chronic goiter, the presence of a mass adherent to deep tissue planes, urban origin, and higher TI-RADS/Bethesda categories were associated with DTC. These findings could contribute to improving criteria for surgical referral in endemic areas with limited resources. Further studies are needed to explore local environmental and geochemical factors and their possible relationship with thyroid carcinogenesis.
.
Downloads
References
Sitges-Serra A. Estado actual: el carcinoma papilar de tiroides después de Mazzaferri. En: Gómez-Ramírez J, editor. Controversias en el manejo del carcinoma papilar de tiroides. Madrid: Arán; 2018. p. 11-2. (Monografías de la AEC).
Cardona A. Estudio médico psicológico del bocio en una población del área rural. Gac Med Bolivia. 1989;13(1):1-8.
Sernaqué-Mechato R, Pavia-Puga S. Bocio multinodular intratorácico. Rev Soc Peru Med Interna. 2024;37(1):43-47.
Virtual elimination of iodine deficiency disorders in Bolivia. Rev Panam Salud Publica. 1997;2(3):215-219.
Urquieta Maldonado MA, Urquieta Márquez MA, Gutiérrez Cruz D, et al. Perfil bociógeno en estudiantes de Camata Marka, mediante palpación semiológica y respaldo ultrasonográfico. Un estudio de corte transversal. Gestión 2014. Rev Med La Paz. 2015;21(2):32-37.
Calé J, Lutfi RJ. El litio y su influencia en la función tiroidea. Rev Argent Endocrinol Metab. 2009;46(3):37-42.
Daza A. Cáncer diferenciado de tiroides atención en un hospital de tercer nivel de Bolivia. Gac Med Bol. 2024;47(2):40-48.
Amin MB, Edge SB, Greene FL, et al., eds. AJCC cancer staging manual. 8th ed. Cham: Springer; 2017.
Orellana-Suárez KD, Alcívar-Quiroz BM, Salazar-Figueroa GV. Factores de riesgo y manifestaciones clínicas en cáncer de tiroides en adultos en Latinoamérica. MQRInvestigar. 2023;7(3):868-884.
Ali MA, ElMakki Ahmed M. Risk of malignancy in long-standing goiters: a retrospective study at Khartoum Teaching Hospital, Sudan. Cureus. 2025;17(6):e86931.
Pitoia F, Califano I, Vázquez A, et al. Consenso intersocietario sobre tratamiento y seguimiento de pacientes con cáncer diferenciado de tiroides. Rev Argent Endocrinol Metab. 2014;51(2):85-118.
Burman KD, Wartofsky L. Clinical practice. Thyroid nodules. N Engl J Med. 2015;373(24):2347-2356.
Kim M, Jeon MJ, Han M, et al. Tumor growth rate does not predict malignancy in surgically resected thyroid nodules classified as Bethesda category III with architectural atypia. Thyroid. 2019;29(2):216-221.
Smith JJ, Chen X, Schneider DF, et al. Cancer after thyroidectomy: a multi-institutional experience with 1,523 patients. J Am Coll Surg. 2013;216(4):571-577.
American Cancer Society. Thyroid cancer risk factors [Internet]. Atlanta: American Cancer Society; 2019 [citado 2025 jul 10]. Available from: https://www.cancer.org/cancer/types/thyroid-cancer/causes-risks-prevention/risk-factors.html.
Lan Z, Yang F, Zhang J, et al. Diagnostic value and challenges of BRAF V600E molecular testing and thyroid fine-needle aspiration cytology: a retrospective study from a tertiary institution in Southern Hunan Province, China. Acta Cytol. 2023;67(6):629-638.
Asanuma K, Kobayashi S, Shingu K, et al. The rate of tumour growth does not distinguish between malignant and benign thyroid nodules. Eur J Surg. 2001;167(2):102-105.
Mota Gamboa JD, García Tamayo J. Carcinoma indiferenciado de la glándula tiroides: estudio histológico e inmunohistoquímico en cinco casos. Rev Fac Med. 2002;25(1):115-120.
Huston-Paterson HH, Mao Y, Tseng CH, et al. Rural-urban disparities in the continuum of thyroid cancer care: analysis of 92,794 cases. Thyroid. 2024;34(5):635-645.
Huang EYF, Kao NH, Lin SY, et al. Concordance of the ACR TI-RADS classification with Bethesda scoring and histopathology Risk stratification of thyroid nodules. JAMA Netw Open. 2023;6(9):e2331612.
Linhares SM, Handelsman R, Picado O, et al. Fine needle aspiration and the Bethesda system: correlation with histopathology in 1,228 surgical patients. Surgery. 2021;170(5):1364-8. DOI: https://doi.org/10.1016/j.surg.2021.05.016.
Apodaca Cruz A, Vázquez Islas G, Torres Jiménez J, et al. Urgencias metabólicas. En: Herrera-Gómez A, Ñamendys-Silva SA, Meneses-García A, editores. Manual de oncología: procedimientos médico-quirúrgicos. 6a ed. México: McGraw-Hill Education; 2017. p. 152-159.
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133.
Orois A, Mora M, Halperin I, et al. Carcinoma diferenciado de tiroides familiar: más allá de las formas sindrómicas. Endocrinol Diabetes Nutr. 2021;68(4):260-269.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Alvaro Daza Mier

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.










